Literature DB >> 22659528

Associations between small dense LDL, HDL subfractions (HDL2, HDL3) and risk of atherosclerosis in Japanese-Americans.

Shusaku Maeda1, Shuhei Nakanishi, Masayasu Yoneda, Tomokazu Awaya, Kiminori Yamane, Tsutomu Hirano, Nobuoki Kohno.   

Abstract

AIM: Small dense low-density lipoprotein (sdLDL) has been suggested to be more atherogenic than large buoyant LDL. High-density lipoprotein (HDL) consists of two major subfractions (HDL2, HDL3), and just as controversy remains regarding which of the two is the more powerful negative risk factor for atherosclerosis, associations between sdLDL and these HDL subfractions are unclear.
METHODS: We measured sdLDL cholesterol (sdLDL-C), HDL2 cholesterol (HDL2-C) and HDL3 cholesterol (HDL3-C) by a newly developed method in 481 Japanese-Americans who were not using lipid-lowering medication, and examined the associations of these cholesterol concentrations with variables related to atherosclerosis.
RESULTS: In multivariate analysis, sdLDL-C was positively correlated with the body mass index (BMI), fasting glucose and insulin, 2-h glucose, HOMA-IR, high sensitivity C-reactive protein (hsCRP), and carotid artery intima-media thickness (IMT) after adjustment for age and sex. In particular, sdLDL-C was positively correlated with IMT, even after adjustment for sex, age, smoking status, hypertension, diabetes mellitus and hsCRP. HDL2-C was more closely inversely correlated than total HDL-C with BMI, fasting glucose and insulin, 2-h glucose, HOMA-IR, and hsCRP, whereas HDL3-C was not correlated with these factors. Additionally, HDL2-C was more closely correlated than total HDL-C or HDL3-C with sdLDL-C, LDL-C, triglycerides (TG), and apolipoprotein B (apoB).
CONCLUSIONS: SdLDL-C was closely associated with insulin resistance and glucose tolerance, lending credence to its potential as a useful risk marker in assessing carotid artery IMT and the present degree of atherosclerosis in Japanese-Americans. The findings also suggest that subjects with higher HDL2-C levels were better protected from atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22659528     DOI: 10.5551/jat.11445

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN: 1340-3478            Impact factor:   4.928


  25 in total

1.  Subfractions of High-Density Lipoprotein-Cholesterol and Carotid Intima-Media Thickness: The Northern Manhattan Study.

Authors:  Eduard Tiozzo; Hannah Gardener; Barry I Hudson; Chuanhui Dong; David Della-Morte; Milita Crisby; Ronald B Goldberg; Mitchell S V Elkind; Ying Kuen Cheung; Clinton B Wright; Ralph L Sacco; Moise Desvarieux; Tatjana Rundek
Journal:  Stroke       Date:  2016-05-10       Impact factor: 7.914

2.  The profile of HDL-C subfractions and their association with cardiovascular risk in the Hungarian general and Roma populations.

Authors:  Peter Piko; Zsigmond Kosa; Janos Sandor; Ildiko Seres; Gyorgy Paragh; Roza Adany
Journal:  Sci Rep       Date:  2022-06-28       Impact factor: 4.996

3.  Do HDL and LDL subfractions play a role in atherosclerosis in end-stage renal disease (ESRD) patients?

Authors:  Anna Gluba-Brzózka; Beata Franczyk; Maciej Banach; Magdalena Rysz-Górzyńska
Journal:  Int Urol Nephrol       Date:  2016-12-09       Impact factor: 2.370

4.  New automated assay of small dense low-density lipoprotein cholesterol identifies risk of coronary heart disease: the Multi-ethnic Study of Atherosclerosis.

Authors:  Michael Y Tsai; Brian T Steffen; Weihua Guan; Robyn L McClelland; Russell Warnick; Joseph McConnell; Daniel M Hoefner; Alan T Remaley
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-11-14       Impact factor: 8.311

5.  Carotid artery plaque in women with rheumatoid arthritis and low estimated cardiovascular disease risk: a cross-sectional study.

Authors:  Alfonso Corrales; Patrick H Dessein; Linda Tsang; Trinitario Pina; Ricardo Blanco; Carlos Gonzalez-Juanatey; Javier Llorca; Miguel A Gonzalez-Gay
Journal:  Arthritis Res Ther       Date:  2015-03-11       Impact factor: 5.156

6.  Hypertriglyceridemia is a major factor associated with elevated levels of small dense LDL cholesterol in patients with metabolic syndrome.

Authors:  Yonggeun Cho; Sang Guk Lee; Sun Ha Jee; Jeong Ho Kim
Journal:  Ann Lab Med       Date:  2015-11       Impact factor: 3.464

7.  Additive effects of postchallenge hyperglycemia and low-density lipoprotein particles on the risk of arterial stiffness in healthy adults.

Authors:  Cheng Ding; Sandy Huey-Jen Hsu; Yong-Jian Wu; Ta-Chen Su
Journal:  Lipids Health Dis       Date:  2014-11-27       Impact factor: 3.876

8.  Effects of switching to low-dose rosuvastatin (5 mg/day) on glucose metabolism and lipid profiles in Japanese patients with type 2 diabetes and dyslipidemia: a single-arm, prospective, interventional trial.

Authors:  Akiko Kameda; Akinobu Nakamura; Yoshinobu Kondo; Mari Kimura; Yasuo Terauchi
Journal:  Diabetol Int       Date:  2017-07-05

9.  Cholesterol forms and traditional lipid profile for projection of atherogenic dyslipidemia: lipoprotein subfractions and erythrocyte membrane cholesterol.

Authors:  Hüseyin Avni Uydu; Mehmet Bostan; Mehtap Atak; Adnan Yılmaz; Adem Demir; Buket Akçan; Fatih Sümer; Nimet Baltaş; Zakir Karadağ; Yavuz Uğurlu; Asım Orem
Journal:  J Membr Biol       Date:  2013-11-16       Impact factor: 1.843

10.  Losartan Inhibits Nuclear Factor-κB Activation Induced by Small, Dense LDL Cholesterol Particles in Human Umbilical Vein Endothelial Cells.

Authors:  Gonghui Guo; Xiaojing Cheng; Rong Fu
Journal:  Curr Ther Res Clin Exp       Date:  2013-03-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.